Cardiology

Back to articles

CV outcomes better with ACEIs than ARBs in patients with diabetes

KEY POINT

Results of a large meta-analysis involving more than 56,000 patients showed that ACE inhibitors (ACEIs) had greater benefits on cardiovascular (CV) outcomes compared with angiotensin receptor blockers (ARBs) in patients with diabetes.